Fertility Blog

Polyendocrine metabolic ovarian syndrome (PMOS), formerly known as PCOS, isn’t a one-size-fits-all condition, and your care shouldn’t be either. Whether you're hoping to regulate your cycle, manage symptoms, or grow your family, finding a specialist who listens, educates, and creates a plan around your goals can make all the difference.

Navigating pregnancy and parenting after loss can bring grief, gratitude, fear, and joy—sometimes all at once. Learn what the term "rainbow baby" means and how to find support throughout this complex journey.

At a glance → 61% of patients surveyed told someone at work about fertility treatment right away, while 30% never disclosed at all → Exhaustion from early morning monitoring was one of the most common work impacts, often more disruptive than patients expected → More paid time off, better insurance coverage for fertility treatment, and dedicated mental health days topped the list of changes patients want from employers

At a Glance → Illume Fertility has been named a 2026 LGBTQ+ Healthcare Equality Leader by the Human Rights Campaign Foundation, the eighth consecutive year earning the designation. → Only 255 of 741 participating healthcare facilities are publicly listed as Leaders in this year's directory, a notable drop from prior years given current legal and political pressures. → The recognition arrives during a year of significant pressure on LGBTQ+ healthcare access, making publicly identifiable inclusive providers harder to find and more important to patients. → For LGBTQ+ intended parents, inclusive care goes beyond welcoming language: it means a clinical team that understands donor conception, reciprocal IVF, gestational surrogacy, and the legal and financial landscape that comes with each path. The Human Rights Campaign Foundation (HRC) released its 2026 Healthcare Equality Index on June 5, 2026, and Illume Fertility has been named a Leader for the eighth year in a row. This year's report arrives in a healthcare landscape where LGBTQ+ care access is being actively debated and, in many states, restricted, which shaped both how facilities participated and how their results are being shared publicly.

Infertility affects millions of people every year, with about 1 in 5 couples in the United States experiencing difficulties getting pregnant or carrying a pregnancy to term. Unfortunately, military insurance coverage still does not fully cover the treatment of infertility connected to service-related injuries. Keep reading to learn about the military discounts we offer here at Illume Fertility and how they can help defray the cost of fertility treatment.

At a glance → A coalition of 56 patient and professional organizations announced on May 12, 2026 that polycystic ovary syndrome will now be called polyendocrine metabolic ovarian syndrome, abbreviated PMOS → The decision followed a 14-year consensus process led by researchers at Monash University, with input from more than 22,000 patients and health professionals across six continents → Adoption will be gradual, with both names appearing in medical records, lab reports, and patient materials until PMOS becomes the standard term → Diagnostic criteria and treatment protocols are not affected by the renaming; fertility care for PMOS uses the same clinical approach as PCOS care In this article, you will find a plain-language breakdown of the PCOS name change, why your diagnosis and care will stay the same, and what the shift could mean for fertility treatment and research, from a reproductive endocrinologist who specializes in the condition.

Behind every positive pregnancy test are months (sometimes years) of hard decisions and small acts of courage that rarely get talked about. For National Infertility Awareness Week, eight Illume Fertility couples opened up about what their road to parenthood actually looked like, detours included.

At a glance → More than 100,000 babies were born through IVF in the U.S. in 2024, a new national record → IVF now accounts for nearly 3% of all U.S. births, or about 1 in 36 babies → Single embryo transfer is now standard for most patients, helping make IVF safer than in the past → National averages are helpful, but your age, diagnosis, ovarian reserve, clinic, lab, and treatment plan matter more As the founder of Illume Fertility, I’ve followed national IVF outcome data closely for decades. SART’s newest report matters not only because it set a record, but because it shows how fertility treatment is evolving and what that means for patients considering care today.